These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7150479)

  • 41. Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction.
    Kosmatopoulos K; Algara DS; Orbach-Arbouys S
    J Immunol; 1987 Feb; 138(4):1038-41. PubMed ID: 3492538
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of graft-versus-host reaction on the immune response to alloantigens and growth of a syngeneic tumor.
    Zaleski M
    Exp Hematol; 1975 Jan; 3(1):12-21. PubMed ID: 238866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mls-1a-induced peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras. Modification of T cell repertoire associated with active suppression and permanent presentation of host antigens.
    Miconnet I; Bruley-Rosset M; Halle-Pannenko O
    J Immunol; 1992 Jun; 148(12):3706-13. PubMed ID: 1534822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experimental studies of immunologically mediated enteropathy: IV. Correlation between immune effector mechanisms and type of enteropathy during a GvHR in neonatal mice of different ages.
    Felstein MV; Mowat AM
    Clin Exp Immunol; 1988 Apr; 72(1):108-12. PubMed ID: 3396213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 46. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S; Nakao Y; Smith RT
    Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract]   [Full Text] [Related]  

  • 47. Abrogation of the lethal graft-vs.-host reaction developed to non-H-2 antigens: involvement of T suppressor cells distinct from veto cells.
    Halle-Pannenko O; Pritchard LL; Bruley-Rosset M
    Eur J Immunol; 1987 Dec; 17(12):1751-5. PubMed ID: 2961574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum-mediated inhibition of graft-vs.-host reaction.
    Cauchi MN; Dawson KB
    J Exp Med; 1975 Jul; 142(1):248-52. PubMed ID: 239089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of F1 cytotoxic potentials by GvHR: suppression of cytotoxic T cell responses of F1 mice correlates with F1 inability to resist the proliferation of GvHR-inducing parental T lymphocytes.
    Ishikawa H; Kubota E; Wilkinson NM; Saito K
    J Immunol; 1982 Sep; 129(3):1181-8. PubMed ID: 6213709
    [No Abstract]   [Full Text] [Related]  

  • 50. Cyclophosphamide-induced graft-versus-host immunotolerance.
    Van Winkle MG
    J Reticuloendothel Soc; 1971 Nov; 10(5):403-17. PubMed ID: 4399566
    [No Abstract]   [Full Text] [Related]  

  • 51. Further development of a successful protocol of graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ; Esparza AR; Flinton LJ; Simon JD; Kelley RJ; Albala MM
    Cancer Res; 1977 Oct; 37(10):3494-6. PubMed ID: 20223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolated peripheral T cells from GvHR recipients exhibit defective IL-2R expression, IL-2 production, and proliferation in response to activation stimuli.
    Levy RB; Jones M; Cray C
    J Immunol; 1990 Dec; 145(12):3998-4005. PubMed ID: 1979582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The influence of the graft versus host reaction on the growth of syngenous sarcoma in mice].
    Shcherbakov VIa; Semenkov VF
    Biull Eksp Biol Med; 1973 Feb; 74(2):70-3. PubMed ID: 4155646
    [No Abstract]   [Full Text] [Related]  

  • 54. Tumor induction by immunologically activated murine leukemia virus.
    Armstrong MY; Ruddle NH; Lipman MB; Richards FF
    J Exp Med; 1973 May; 137(5):1163-79. PubMed ID: 4144984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immune deficiency associated with experimental graft-versus-host reaction. Lack of correlation with T-cell cytotoxic activity].
    Lang P; Bierre V; Cholin S; Rostoker G; Weil B
    Presse Med; 1991 Nov; 20(40):2012-4. PubMed ID: 1837114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunologic control of the ascites of murine adenocarcinoma 755. I. Protection with syngeneic immune serum or lymphoid cells.
    Haagensen DE; Roloson G; Collins JJ; Wells SA; Bolognesi DP; Hansen HJ
    J Natl Cancer Inst; 1978 Jan; 60(1):131-9. PubMed ID: 628013
    [No Abstract]   [Full Text] [Related]  

  • 57. Effects of graft-versus-host reaction on intrahepatic islet transplants.
    Li H; Ricordi C; Inverardi L
    Diabetes; 1999 Dec; 48(12):2292-9. PubMed ID: 10580416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protection from lethal graft-vs.-host disease by donor stem cell repopulation.
    Rozendaal L; Pals ST; Melief CJ; Gleichmann E
    Eur J Immunol; 1992 Feb; 22(2):575-9. PubMed ID: 1347016
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effects of burn injury on the reactivity of spleen cells of mice of different genotypes during regional graft vs host reaction].
    Barsukov AN; Fedorov GN; Semenkov VF
    Biull Eksp Biol Med; 1990 Jun; 109(6):592-4. PubMed ID: 2397303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.